Peter K Honig MD MPH

Clinical Pharmacology

Private Equity

500 Arcola RoadCollegeville, PA 19426

Dr. Honig is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Honig's full profile Already have an account?

Summary

Dr. Peter Honig, based in Collegeville, PA, specializes in Internal Medicine with a subspecialty in Clinical Pharmacology. He completed his medical education at Columbia University Vagelos College of Physicians and Surgeons, followed by a residency at McGaw Medical Center and further training in Clinical Pharmacology at the Uniformed Services University. Additionally, he earned an MPH from Columbia University School of Public Health. Dr. Honig is currently the Managing Director at Blackstone Life Sciences and has previously held senior vice president roles at Pfizer, AstraZeneca, and Merck Research Labs, as well as served as a Medical Officer at the FDA. His recent publications in reputed journals have explored topics like human error detection and Bayesian approaches in drug development. Dr. Honig has received several honors, including the FDA Alumni Award and the Gary Neil Innovation in Drug Development Award.

Education & Training

Uniformed Services University of the Health Sciences F. Edward Hebert School of MedicineClincal Pharmacology, 1990 - 1992
Columbia University School of Public HealthMPH, 1986 - 1989
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1982 - 1985
Columbia University Vagelos College of Physicians and SurgeonsClass of 1982

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Awards, Honors, & Recognition

FDA Alumni Award FDA, 2020
Gary Neil Innovation in Drug Development Award ASCPT, 2016
Sol Katz Excellence in Teaching Award Georgetown University Dept of Medicine, 1996

Publications & Presentations

PubMed

54 citations
Application of Bayesian approaches in drug development: starting a virtuous cycle.
Stephen J Ruberg, Francois Beckers, Rob Hemmings, Peter Honig, Telba Irony
Nature Reviews. Drug Discovery. 2023-03-01
8 citations
The "Coming of Age" of Real-World Evidence in Drug Development and Regulation.
Peter K Honig
Clinical Pharmacology and Therapeutics. 2022-01-01
23 citations
A Useful and Sustainable Role for N-of-1 Trials in the Healthcare Ecosystem.
Harry P. Selker, Theodora Cohen, Ralph B. D'Agostino, Willard H. Dere, S. Nassir Ghaemi
Clinical Pharmacology and Therapeutics. 2021-10-20